Healio (8/16, Jenkins) reported, “Benzodiazepineswere associated with increased risk for CHD, HF and CV mortality among patients with insomnia, according to a study.” In order “to investigate the association between regular use of Z-drugs (eszopiclone, zolpidem and zaleplon) and benzodiazepines (lorazepam, alprazolam, diazepam and triazolam) and CV outcomes – including CHD, HF, stroke and CV mortality – among patients with insomnia,” investigators “used multivariable Cox proportional hazard models to analyze data from 124,445 U.K. Biobank participants aged 40 to 69 years with insomnia.” The findings were published in the European Journal of Preventive Cardiology.
Related Links:
— “Benzodiazepine use may carry CV risks among patients with insomnia,”Cassandra Jenkins, Healio , August 16, 2024